SAI
VCYT icon

Systematic Alpha Investments’s Veracyte VCYT Stock Holding History

Systematic Alpha Investments’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,700
Closed -$240K – 241
2025
Q4 		$240K Buy
+5,700
New +$230K 0.01% 206

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Systematic Alpha Investments's VCYT Position: Q1 2026 in Review

Systematic Alpha Investments sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 5,700 shares — an estimated $240K sold.

Systematic Alpha Investments first reported a position in VCYT in Q4 2025 and held it in 1 quarter. The position peaked at $240K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Systematic Alpha Investments reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
  • Systematic Alpha Investments sold 5,700 Veracyte shares in Q1 2026, an estimated $240K.
  • Systematic Alpha Investments first reported a position in Veracyte in Q4 2025 and held it in 1 quarter.
  • Systematic Alpha Investments's Veracyte position peaked at $240K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Systematic Alpha Investments's 13F filing for Q1 2026, filed 18 May 2026.